Opsoclonus-myoclonus-ataxia syndrome as a complication of pembrolizumab treatment in an adult patient (a case report and literature review)

Background. Opsoclonus-myoclonus-ataxia syndrome (OMAS) in adults is an extremely rare condition, often leading to rapidly deteriorated neurological performance. The majority of published cases are considered as being of post-infectious, paraneoplastic or idiopathic origin. However, there have been...

Full description

Saved in:
Bibliographic Details
Main Authors: K. A. Rumiantseva, A. Yu. Polushin, N. Kh. Abduloeva, Ya. B. Skiba, V. M. Moiseenko
Format: Article
Language:Russian
Published: IRBIS LLC 2023-03-01
Series:Эпилепсия и пароксизмальные состояния
Subjects:
Online Access:https://www.epilepsia.su/jour/article/view/876
Tags: Add Tag
No Tags, Be the first to tag this record!